Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapies
Mark P Chao Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA Abstract: Over the last few decades, advances in immunochemotherapy have led to dramatic improvement in the prognosis of non-Hodgkin’s lymphoma (NHL). Despite these advances, relap...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-08-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/treatment-challenges-in-the-management-of-relapsed-or-refractory-non-h-a14143 |